Latus Bio
PrivateLast Round
Series A
May 4, 2026
Total Funding Raised
$194M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Latus Bio is a biotechnology company that develops precision gene therapies for central nervous system and peripheral diseases using proprietary AAV capsid engineering and computational discovery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Latus Bio Comparables
Compare Latus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 84% | |
| Capsigen | 84% | |
| Apertura Gene Therapy | 84% | |
Latus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2026 | ||||
| Series A | May 2, 2024 |
Latus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Helen's Pink Sky Foundation | Series A |
| Benjamin Franklin Technology Partners | Series A |
| DCVC Bio | Series A |
| Gaingels | Series A |
| Korea Development Bank | Series A |
| BioAdvance Capital | Series A |
| 8VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$97M round led by 8VC and DCVC Bio.
- Nov 3, 2025
Launched an AI/ML strategy for AAV gene therapy and added two scientific advisors.
Latus Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Latus Bio's valuation, stock price, and market status.